← Open Payments lookup

THOMAS STROSS: Open Payments

NPI 1811391063 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,809 in 91 payments from 13 companies in 2025. Trend: 2023 $1,503 · 2024 $847 · 2025 $1,809

Food & beverage: $1,809
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$401
Alkermes, Inc.9$273
Otsuka America Pharmaceutical, Inc.21$222
Teva Pharmaceuticals USA, Inc.15$195
E.R. Squibb & Sons, L.L.C.6$188
Novo Nordisk Inc1$115
ABBVIE INC.4$99
Vanda Pharmaceuticals Inc.3$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$73
Lundbeck LLC3$71

Products named: INGREZZA, REXULTI, LYBALVI, COBENFY, Ozempic, AUSTEDO XR, VRAYLAR, UZEDY.

Industry payments across FL — which companies pay providers there.